Skip to content

Human experiment reserach on Chlamydomonas reinhardtii for auxiliary hypoglycemic function

Human experiment reserach on Chlamydomonas reinhardtii for auxiliary hypoglycemic function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068252
Enrollment
Unknown
Registered
2023-02-13
Start date
2022-07-17
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

control group:Placebo, oral, no less than 6g per day
test group:Chlamydomonas reinhardtii, oral, not less than 6g per day

Sponsors

the 983 Hospital of the PLA Joint Service Support Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The (IGR) population with fasting blood glucose of 5.6-7 mmol/L (100-126 mg/dL) or 2-hour postprandial blood glucose of 7.8-11.1 mmol/L (140-200 mg/dL).

Exclusion criteria

Exclusion criteria: 1. Patients with diabetes; 2. People under 18 years old or over 65 years old, pregnant or lactating women, and people allergic to the test sample; 3. Patients with heart, liver, kidney and other major organ complications, or with other serious diseases, mental illness, taking glucocorticoids or other drugs that affect blood glucose; 4. Those who cannot cooperate with diet control and affect the observation results; 5. There are people with diabetes ketosis, acidosis, infection within three weeks, functional gastrointestinal disease, hyperthyroidism in the last three months, and people who have been cured of hyperthyroidism for less than one and a half years; 6. Those who take articles related to the test function in a short time will affect the judgment of the results; 7. Those who do not meet the inclusion criteria, do not take the test sample as required, or do not have complete data that affect the observation results.

Design outcomes

Primary

MeasureTime frame
Fasting and postprandial blood glucose;Diabetes clinical symptom score table;blood lipids;Immune-related health score;Stool test (frequency, condition, character);

Secondary

MeasureTime frame
glycosylated hemoglobin;Oral and postprandial insulin;Fatty liver function (B-ultrasound);uric acid;Pittsburgh sleep quality index, PSQI;

Countries

China

Contacts

Public ContactMeng Yongxia

the 983 Hospital of the PLA Joint Service Support Force

kangao@kaotg.com+86 22 8432 3777

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026